Biosynthesis of heme in mammals

被引:372
作者
Ajioka, Richard S. [1 ]
Phillips, John D. [1 ]
Kushner, James P. [1 ]
机构
[1] Univ Utah, Sch Med, Dept Internal Med, Div Hematol, Salt Lake City, UT 84132 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2006年 / 1763卷 / 07期
关键词
iron; heme; porphyrin; porphyrias;
D O I
10.1016/j.bbamcr.2006.05.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most iron in mammalian systems is routed to mitochondria to serve as a substrate for ferrochelatase. Ferrochelatase inserts iron into protoporphyrin IX to form heme which is incorporated into hemoglobin and cytochromes, the dominant hemoproteins in mammals. Tissue-specific regulatory features characterize the heme biosynthetic pathway. In erythroid cells, regulation is mediated by erythroid-specific transcription factors and the availability of iron as Fe/S clusters. In non-erythroid cells the pathway is regulated by heme-mediated feedback inhibition. All of the enzymes in the heme biosynthetic pathway have been crystallized and the crystal structures have permitted detailed analyses of enzyme mechanisms. All of the genes encoding the heme biosynthetic enzymes have been cloned and mutations of these genes are responsible for a group of human disorders designated the porphyrias and for X-linked sideroblastic anemia. The biochemistry, structural biology and the mechanisms of tissue-specific regulation are presented in this review along with the key features of the porphyric disorders. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:723 / 736
页数:14
相关论文
共 107 条
[1]   Human uroporphyrinogen-III synthase: Genomic organization, alternative promoters, and erythroid-specific expression [J].
Aizencang, G ;
Solis, C ;
Bishop, DF ;
Warner, C ;
Desnick, RJ .
GENOMICS, 2000, 70 (02) :223-231
[2]   Uroporphyrinogen III synthase - An alternative promoter controls erythroid-specific expression in the murine gene [J].
Aizencang, GI ;
Bishop, DF ;
Forrest, D ;
Astrin, KH ;
Desnick, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2295-2304
[3]  
Anderson K.E., 2001, The Metabolib and Molecular Bases of Inherited Disease, P2961
[4]   Recommendations for the diagnosis and treatment of the acute porphyrias [J].
Anderson, KE ;
Bloomer, JR ;
Bonkovsky, HL ;
Kushner, JP ;
Pierach, CA ;
Pimstone, NR ;
Desnick, RJ .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (06) :439-450
[5]  
ANDERSON PM, 1979, J BIOL CHEM, V254, P6924
[6]   Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans [J].
Astner, I ;
Schulze, JO ;
van den Heuvel, J ;
Jahn, D ;
Schubert, WD ;
Heinz, DW .
EMBO JOURNAL, 2005, 24 (18) :3166-3177
[7]   REGIONAL ASSIGNMENT OF THE HUMAN UROPORPHYRINOGEN-III SYNTHASE (UROS) GENE TO CHROMOSOME 10Q25.2-]Q26.3 [J].
ASTRIN, KH ;
WARNER, CA ;
YOO, HW ;
GOODFELLOW, PJ ;
TSAI, SF ;
DESNICK, RJ .
HUMAN GENETICS, 1991, 87 (01) :18-22
[8]  
ASTRIN KH, 1987, ANN NY ACAD SCI, V514, P23
[9]   Molecular mechanisms of dominant expression in porphyria [J].
Badminton, MN ;
Elder, GH .
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (03) :277-286
[10]  
BEVAN DR, 1980, J BIOL CHEM, V255, P2030